Eli Lilly and Co (LLY)
731.88
-13.81
(-1.85%)
USD |
NYSE |
Apr 24, 16:00
724.00
-7.88
(-1.08%)
After-Hours: 18:06
Eli Lilly Total Liabilities (Quarterly): 53.14B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 53.14B |
| September 30, 2023 | 46.61B |
| June 30, 2023 | 43.66B |
| March 31, 2023 | 41.87B |
| December 31, 2022 | 38.71B |
| September 30, 2022 | 37.30B |
| June 30, 2022 | 38.40B |
| March 31, 2022 | 37.46B |
| December 31, 2021 | 39.65B |
| September 30, 2021 | 40.23B |
| June 30, 2021 | 41.15B |
| March 31, 2021 | 39.74B |
| December 31, 2020 | 40.81B |
| September 30, 2020 | 38.95B |
| June 30, 2020 | 37.70B |
| March 31, 2020 | 37.91B |
| December 31, 2019 | 36.59B |
| September 30, 2019 | 34.43B |
| June 30, 2019 | 35.81B |
| March 31, 2019 | 35.44B |
| December 31, 2018 | 33.00B |
| September 30, 2018 | 30.47B |
| June 30, 2018 | 30.74B |
| March 31, 2018 | 29.77B |
| December 31, 2017 | 33.31B |
| Date | Value |
|---|---|
| September 30, 2017 | 28.05B |
| June 30, 2017 | 26.78B |
| March 31, 2017 | 23.52B |
| December 31, 2016 | 24.73B |
| September 30, 2016 | 21.97B |
| June 30, 2016 | 21.82B |
| March 31, 2016 | 19.66B |
| December 31, 2015 | 20.98B |
| September 30, 2015 | 21.06B |
| June 30, 2015 | 21.33B |
| March 31, 2015 | 20.71B |
| December 31, 2014 | 20.92B |
| September 30, 2014 | 16.97B |
| June 30, 2014 | 17.02B |
| March 31, 2014 | 16.41B |
| December 31, 2013 | 17.61B |
| September 30, 2013 | 17.07B |
| June 30, 2013 | 17.99B |
| March 31, 2013 | 17.34B |
| December 31, 2012 | 19.62B |
| September 30, 2012 | 18.26B |
| June 30, 2012 | 17.50B |
| March 31, 2012 | 17.42B |
| December 31, 2011 | 20.12B |
| September 30, 2011 | 17.98B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
34.43B
Minimum
Sep 2019
53.14B
Maximum
Dec 2023
40.01B
Average
38.95B
Median
Sep 2020
Total Liabilities (Quarterly) Benchmarks
| Amgen Inc | 90.92B |
| Biogen Inc | 12.05B |
| Madrigal Pharmaceuticals Inc | 235.21M |
| Vertex Pharmaceuticals Inc | 5.150B |
| Viking Therapeutics Inc | 20.07M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 64.01B |
| Shareholders Equity (Quarterly) | 10.77B |
| Debt to Equity Ratio | 2.342 |
| Current Ratio | 0.9426 |
| Net Debt Paydown Yield | -0.34% |